Non-canonical Wnt receptor Fzd2 and its ligands Wnt5a/b are elevated in metastatic breast cancer cell lines and in high-grade tumors and that their expression correlates with markers of EMT [11]. This evidence concerns the gene WNT5A and breast cancer.